Business | Thomson Reuters | Thursday October 15, 2015
Chandru Chawla, head of Cipla Ltd's new ventures unit, said India's "fundamental disadvantage" over United States, Europe and South Korea was that biotechnology never evolved in India to the extent that chemistry did. "In terms of having the right knowledge ecosystem and the pools of talent, India is far behind," he said.
www.ndtv.com/business